Rheumatoid Arthritis Unknown Status Phase 4 Trials for Adalimumab (DB00051)

Also known as: RA / Rheumatic Arthritis / Arthritis, Rheumatoid / Arthritis,Rheumatoid / Rheumatoid Arthritis (RA) / Rheumatoid Arthritis(RA) / Arthritis, Rheumatoid (RA) / Systemic rheumatoid arthritis / Arthritis rheumatoid / Rheumatoid arthritis, unspecified / R arthritis / Rh arthritis / Atrophic arthritis

IndicationStatusPhase
DBCOND0027961 (Rheumatoid Arthritis)Unknown Status4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01072058Heart Function in Rheumatoid Arthritis and Ankylosing Spondylitis Pre and Post-TNF BlockerScreening
NCT01270035Efficacy and Safety of Adalimumab 80 mg Every Other Week With MethotrexateTreatment
NCT00291915Multicenter Randomized Prospective Trial Comparing Methotrexate Alone or in Combination With Adalimumab in Early ArthritisTreatment
NCT00216177Comparison of Adalimumab and Infliximab Treatment of Rheumatoid ArthritisTreatment
NCT02132234Effects of Biological Treatment on Blood Pressure and Endothelial Function in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing SpondylitisTreatment
NCT01000441Rotation or Change of Biotherapy After First Anti-TNF Treatment Failure for Rheumatoid ArthritisTreatment
NCT01405326REstore Working Ability in RheumatoiD Arthritis